Jpmorgan Chase & CO Beyond Spring Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Beyond Spring Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 600 shares of BYSI stock, worth $1,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
600
Previous 600
-0.0%
Holding current value
$1,205
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BYSI
# of Institutions
19Shares Held
5.61MCall Options Held
248KPut Options Held
0-
Decheng Capital LLC Menlo Park, CA4.53MShares$9.11 Million2.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA524KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA256KShares$514,9860.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$432,8630.0% of portfolio
-
Tanaka Capital Management Inc New York, NY26.3KShares$52,8540.09% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $78.2M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...